Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
editorial
. 2020 May 17;74(8):e13519. doi: 10.1111/ijcp.13519

COVID‐19: Leaving lockdown—Of Schrodinger, cats, testing and masks

George Alexander Thomson 1,
PMCID: PMC7235468  PMID: 32314527

The COVID‐19 pandemic progresses across the globe at pace, bringing lockdown of countries and continents. Over the Easter weekend as well as speculation that lockdown in the UK would need to be extended for a significant period, media attention became focussed on why the UK death rates from COVID‐19 are significantly greater than in Germany. 1 In a BBC television interview on Easter Sunday, 2 Sir Jeremy Farrar who is a senior advisor to both UK and German governments commented that it is likely to be the significantly larger number of tests for SARS‐Cov‐2 (the viral cause for COVID‐19) undertaken in Germany when compared with the UK. He suggested that through early identification and isolation of cases that Germany, unlike the UK, had been able to contain COVID‐19 and hence reduce transmission rates and need for hospitalisation. Focus has also shifted to the use of face masks, prompted by comments made by Dr David Nabbaro to the BBC on Easter Monday who suggested that he thinks widespread public use of facemasks should become the norm. 3

Looking for some brief distraction from the daily news reports, I was drawn to recent apparently random observations that SARS‐Cov‐2 can infect other animal species, especially cats. On 6 April 2020, it was reported that a number of big cats at the Bronx zoo had developed respiratory symptoms, and that a tiger named Nadia had been tested positive for a COVID‐19. 4 , 5 It is assumed that the infection was transmitted by a zookeeper who had fallen ill with COVID‐19 and been in contact with the tiger. 5 Who was brave enough to take a throat swab from a tiger was not revealed.

Recent evidence suggests that cats (but much less so dogs) can be susceptible to infection with COVID‐19, and that the SARS‐Cov‐2 virus replicates efficiently in cats and ferrets. 6

Unlike the big cats at Bronx zoo, the initial infection was artificially induced by large doses of SARS‐Cov‐2, and did not result from exposure to a single infected human. This study demonstrated that the infected cats were asymptomatic but were able to infect other nearby cats through droplets spread thus maintaining the infection chain. The observation has led the Centre for Diseases Control (CDC) to advise people with symptoms of COVID‐19 to minimise contact with their pets, including petting, snuggling and being licked. 5 It should be noted that as yet there is no evidence of pet to human transmission, nor whether cats go on to develop immunity, but it is hard to ignore the possibility that our pets might act as reservoirs for SARS‐Cov‐2. Notwithstanding the possibility that in the months to come there may be herds of cats immune to COVID‐19, it is hard to escape the likelihood that until either human herd immunity or mass vaccination against COVID‐19 becomes a reality, the SARS‐Cov‐2 virus is likely to live on in our communities for some time to come. This is likely to have implications with respect to the need for some form of ongoing non‐pharmaceutical interventions for the foreseeable future.

The recent observations of COVID‐19 infection in cats brought to mind recent social media posts remembering Erwin Schrodinger's ‘at paradox paper’ 7 —colloquially referred to as Schrodinger's cat. Given the lack of mass community testing for SARS‐Cov‐2 in most countries to date, the posts suggested that COVID‐19 could be considered to be the ‘Schrodinger's virus’. Unfortunately, it is not possible to cite an original author as the nature of social media posts usually obscure the origin, but whoever came up with the concept in to be commended, and if they can be identified should take significant credit.

In 1935, Schrodinger attempted to describe a paradox in quantum mechanics which suggests that physical objects can simultaneously exist in any possible state at any given point in time. The paradox was postulated by Einstein, and Schrodinger sought to explain the concept to those with the more average mind. Briefly, he described a cat placed in a sealed box in which the observer could not see the cat. In the box was a vial of deadly poison gas, which would be released upon the random degeneration of a radioactive substance. He explained that at any given time, the cat will either be alive or dead, but the observer would not know which state existed for the cat. Therefore, the cat must be assumed to be both alive and dead at the same time. While Schrodinger's concept may seem macabre, it has great relevance to COVID‐19 in a situation where scientists remain in the dark as to the actual extent of community wide infection rates. Likening Schrödinger's cat to ‘Schrodinger's virus’ is therefore highly relevant. There is good evidence that people infected with COVID‐19, who by definition must be considered to be infectious, are often asymptomatic 8 or presymptomatic. 9 Without regular mass testing of whole populations, it is thus impossible to know in what state (previously infected and thus probably immune, currently infected or not infected) anyone we meet exists. This applies to both healthcare setting interactions and also any person‐to‐person interaction in the community—hence ‘Schrodinger's virus’. Therefore, in the light of a lack of widespread testing, every human‐to‐human interaction has to be assumed to be both an opportunity to infect the other person or be infected by them.

This paradox emphasises the need for global leaders of health, national and international policy, to urgently address what measures are necessary to prevent the further spread of COVID‐19. National and international lockdown policies cannot stay in place forever, and many are now discussing exit strategies. A recent study, yet to be peer‐reviewed, but already shared via the SSRN community, 10 explores the impact of nationwide policies for wearing a face mask in public. The authors point out that the data on COVID‐19 to date show that in countries (all SE Asian) where the universal wearing of facemasks is the norm, there is a significant reduction in average daily growth rates of confirmed COVID‐19 infection (10% vs 18%). They also model substantial societal and financial benefits through reduced COVID‐19 transmission, healthcare burden, suffering and deaths. It is important to note that their modelling is based on the use of home‐made cloth face masks, preserving medical masks for frontline health and social care staff. The CDC in the United States have also released a recommendation on the use of cloth face masks in public settings. 9

There has been debate for years on the effectiveness of facemasks to prevent viral transmission in both community and healthcare settings. 11 However, notwithstanding the data on COVID‐19 infection rates highlighted recently, 9 , 10 there are now fairly compelling data to support widespread use of facemasks. If used consistently, as is likely at a time of pandemic, masks have been shown to significantly reduce transmission from people infected with respiratory pathogens to others 12 with a reduction of 3.4‐fold in viral aerosol shedding of influenza virus demonstrated through the use of facemasks in another study. 13 For healthcare workers, much emphasis has been placed on the difference between aerosol and droplet spread and the lack of evidence for face masks with the latter. However, investigators studying the potential benefit of N95 masks vs conventional medical masks concluded that this distinction between aerosol and droplets was an oversimplification. 14 They showed that N95 masks, which are masks that are tight fitting and filtered, provided significantly greater protection than standard medical masks against contracting respiratory infection in healthcare workers. Importantly, the relative risk of laboratory confirmed viral infections overall was reduced to just 0.46 (95% CI 0.23‐0.91) when compared with medical masks, and droplet transmission had an even greater reduction in relative risk to just 0.26 (95% CI 0.16‐0.42) using N95 masks.

The world will inevitably move towards some form of relaxation of lockdown in the not too distant future, and this is important for societal, mental health and economic reasons.

However, it is important that COVID‐19 does not re‐emerge in epidemic proportions again as a result, with similar devastating consequences to those that we are seeing at present. There appears to be a strong body of evidence, and also guidance from respected international authorities to support the use of simple, society wide home‐made face masks and the use of better protection for healthcare workers exposed to the risk of COVID‐19. Hopefully, combined with ongoing social distancing measures, and availability of widespread testing facilities to support isolated quarantine, such an approach might mitigate against the resurgence of COVID‐19 as lockdown measures are relaxed.

As Dr Nabarro advised the BBC over Easter, there is also a strong case for a thorough evidence‐based review of which masks should be used when, and in what settings. Perhaps, were Schrödinger's cat alive, and obviously dead at the same time, in the age of COVID‐19, it would have chosen to wear a mask and also preserve a typically indifferent feline distance from strangers.

REFERENCES


Articles from International Journal of Clinical Practice are provided here courtesy of Wiley

RESOURCES